Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands

Similar documents
National Center for Tumor Diseases (NCT) Heidelberg, Germany

The Centre for Disease Prevention and Control, Latvia

Central Manchester University Hospitals NHS Foundation Trust, UK

Hospital Carlos Haya. Malaga, Spain

Hospital Universitario de Getafe (Getafe Universitary Hospital), Spain

Ministry for Health, the Elderly and Community Care, Malta

Schoen Kliniken group, Schoen Klinik Hamburg Eilbek, Dept. of neurology and. neurorehabilitation, Germany

European Society of Cardiology, France

Erasmus MC, Center for lysosomal and metabolic diseases, Netherlands

RED CELL PATHOLOGY UNIT. HOSPITAL CLINIC-UNIVERSITY OF BARCELONA, Spain

INSTITUTE OF CHILD HEALTH, Greece

Department of Medical Genetics, Medical School, University of Athens, Greece

SERVICIO DE NEUROCIRUGÍA PEDIÁTRICA. HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Spain

Scandinavian Ear Reconstruction Centre, Dept of Plastic and Reconstructive Surgery, SWEDEN

Cystic Fibrosis Europe (CFE), Germany

Castilla y leon Regional Health Service (Gerencia Regional de Salud de Castilla y León)

VSOP, Lupus Netherlands

Riga East University hospital stationary Infectology Center of Latvia (RAKUS LIC), Latvia

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

UNION EUROPÉENNE DES MÉDECINS SPÉCIALISTES

European Reference Networks (ERN) Guide for patient advocates

European Haemophilia Consortium

WORK PLAN 2017 LAURENCE BALLIEUX NATIONAL FOCAL POINT. 1 EU 3rd HEALTH PROGRAMME

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

ERN board of Member States

A European workforce for call centre services. Construction industry recruits abroad

Council, 25 September 2014

Annex 3 Information and Communication Requirements EEA and Norway Grants

National Plans for Rare Diseases The French plan Ségolène Aymé Orphanet On behalf of Alexandra Fourcade French Ministry of Health

116 Help Lines for Rare Diseases

ERN Assessment Manual for Applicants

Education and Training Committee, 5 June 2014

ERN Assessment Manual for Applicants 2. Technical Toolbox for Applicants

EUCERD Joint Action WP7 Workshop From Centres of Expertise for Rare Diseases to European Reference Networks

Connecting Continents: Where now for Australian - European cooperation?

Info Session Webinar Joint Qualifications in Vocational Education and Training Call for proposals EACEA 27/ /10/2017

FAQ Education Empowerment Justice Programme (EEJ Programme)

EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organisations

Document: Report on the work of the High Level Group in 2006

The Seventh Framework Programme for candidate and potential candidate countries European Regional Economic Forum Nova Gorica, 30 May 2007

QUICK REFERENCE TO CALDICOTT & THE DATA PROTECTION ACT 1998 PRINCIPLES

Programme Officer International Development

Introduction to ibmg. Marco Varkevisser Director of Education

European Funding Opportunities in the field of Language Teaching and Learning

European Reference Networks: strategic value for the Member States. Perspective of France

Jean Monnet support to associations

Member webinar: What is an ideal European Reference Network? Matt Johnson, EURORDIS 10 February 2016

Implementing the 3rd Health Programme. Ingrid Keller Coordinator Health Programme Consumer, Health and Food Executive Agency

Call for Nominations. CARLOS V European Award

Copernicus Incubation Programme

Erasmus+ Programme Jean Monnet Activities. Snejina Nikolova Education, Audiovisual and Culture Executive Agency (EACEA)

Presentation of Interreg Europe

Regulation on the implementation of the European Economic Area (EEA) Financial Mechanism

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. Report on the interim evaluation of the «Daphne III Programme »

Presenting the European Investment Advisory Hub Annual Forum of the EUSDR, 2015 Ulm. European Investment Advisory Hub 1

Regulatory Cooperation in Europe. Natalie McCoy, CEER Secretary General INOGATE Conference - Brussels, 1 February 2013

Background paper. Cross-border healthcare in the EU

Assessment of Erasmus+ Sports

Spreading Excellence and Widening Participation in Horizon 2020

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

Call for proposals EAC / S01 / Pilot project for the development of Sector Skills Alliances. Frequently asked questions (updated on 22/06/2012)

Horizon 2020 LEIT-Space

Announcement for open call Fund for Bilateral Relations at National Level Initiatives within the priority areas

Erasmus Mundus José Gutiérrez Fernández Erasmus Mundus Programme Coordinator EACEA

Hospital Pharmacists making the difference in medication use

Executive Report to the European Commission on newborn screening in the European Union

2011 Call for proposals Non-State Actors in Development. Delegation of the European Union to Russia

Summary of a Survey on the Europe 2020 Flagship Initiative Innovation Union. Executive Summary

The Pharmaceutical Risk Assessment Committee (PRAC) of the EMA

VASCERN 1st Annual Seminar Paris, France October 2017

Developing a European Registry for Rare Anaemias

The following passage wants to illustrate the insufficiencies in CF care the patients, their families and care giver struggle with:

Call text. The Programme supports 6 fellows working on projects of a duration up to 36 months recruited in the current call for proposals.

EUROPEAN EXTERNAL ACTION SERVICE

EPF Workshops on Cross-Border Healthcare 1st Stop: Croatia Meeting Report

The Third EU Health Programme

EEA and Norway Grants digital annual report 2018

Do terms like FP6, CORDIS, Specific Programme, Call for

Responsible medication processes ( pharmaceutical care ) and good pharmaceutical practices for improved patients quality of life and batter healthcare

Council of the European Union Brussels, 8 September 2014 (OR. en) Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union

Euro Health Consumer Index 2009

Brokerage for the first ProSafe Call Dina Carrilho Call Secretariat Foundation for Science and Technology (FCT), Portugal

Commissioning Policy (WM12) Patients Changing Responsible Commissioner. Version 2 February 2012

Simona Bovha, CPCM European Investment Bank. European Investment Advisory Hub

Call for the expression of interest Selection of six model demonstrator regions to receive advisory support from the European Cluster Observatory

Amending the Certificate of Current Professional Status template

SMALL COLLABORATIVE PARTNERSHIPS

A shared agenda for growth: European Commission Services

International dimension of Higher Education 27/06/2015

Acting Together: How to continue to provide high quality and universally accessible health services in a financially sustainable way in Europe.

FP7: Marie Curie Actions

1. Have you or a member of your family had first-hand experience of an adverse event or experienced harm in a healthcare setting in your country?

European Reference Networks. Guidance on the recognition of Healthcare Providers and UK Oversight of Applications

TUITION FEE GUIDANCE FOR ERASMUS+ EXCHANGE STUDENTS Academic Year

ERC - European Research Council. Platform Wiskunde Nederland 17 September 2012, Delft. Challenge the future

FUNDING NATURAL HERITAGE PROJECTS IN SCOTLAND LIFE+ NATURE AND BIODIVERISTY

PCNE 2013 Working Conference Workshop 1 Medication Review Update lecture

A common training framework for hospital pharmacy. What is it, and what are the legal aspects?

Study on cross-border health services: enhancing information provision to patients

Transcription:

Radboud University Nijmegen Medical Centre, department of Neurology, Netherlands 1.1 Please indicate the type of organisation on behalf of which you are responding to this consultation: 1. Respondent Profile Health professionals' organisations (e.g. doctors, nurses, managers) Please indicate level: National level organisation Please indicate for what the administration is responsible: 1.1.1. Other (please specify): 1.2 Please indicate the name of your organisation or centre: Radboud University Nijmegen Medical Centre, department of Neurology 1. Please indicate the country where your organsation/centre is located/has its headquarters or main representative office in Europe: 1. Please indicate the number of EU Member States and EEA countries (Norway, Iceland, Lichtenstein) and accessing country (Croatia) in which your organisation conducts business/is represented: 1.5 If need be, can we contact you by e-mail to obtain further information on your submission? 1.5.1 Please provide an e-mail address where we can contact you: 1.6 Please provide us with a contact person (incl jobtitle and daytime phone number): 1.7 Please provide additional contact details if needed: NL b.vandewarrenburg@neuro.umcn.nl Dr. BPC van de Warrenburg, neurologist / assistant professor, 001-6196

2. Involvement of your organisation in the matter of centres of excellence/reference (COE) and healthcare networks in highly specialised healthcare (HSHC). 2.1 How would you describe your organisation's knowledge of High CoE and HSHC? 2.1.1 Space for further comments: 2.2. What aspects or domains related to the topic of CoE and HSHC would correspond to your organisation's key knowledge? (cross any that applies) Highly specialised healthcare provision Management and organisational aspects of highly specialized healthcare Professional performance, clinical practice, quality and safety of specialized healthcare Assessment/evaluation/certification of clinical practice and healthcare providers Engineering/e-health 2.2.1. Space for further comments: 2. Is highly specialised healthcare a priority in your organisation's strategies and work plans? 2..1 Space for further comments: 2.. What specific field of healthcare services/specialities are most relevant for your centre/organisation's field of work? Please specify: 2.5. Has your organisation/centre been directly involved in the design or assessment of professional standards and criteria related with highly specialised healthcare? Very high Medical speciality neurologicval movement disorders Frequently

2.5.1 Please describe your role in such actions/projects: Our involvement in national and international (para)medical guidelines for Parkinson disease, cerebellar ataxia and dystonia. Currently drafting the 'standard of care' document for ataxia. 2.6. Has your organisation been involved in projects/activities supported by the Commission in relation with HSHC or professional and technical criteria/standards in highly specialised healthcare? 2.7. Do you have concrete examples based on your own organisation's experience or could you provide us with references or links to documents related with professional criteria and standards in highly specialised healthcare/coe or HSHC (e.g. quality criteria, guidelines, consensus documents)? No 2.7.1 Space for further comments: See under 2.5.1. We are Centre of Excellence for Parkinson's disease (NPF) and Centre of Expertise for Ataxia (Orphanet). 2.1. What is the scope of the network? 2.1. Which kind of network? 2.1.1 Space for further comments: 2.15. Would you be interested in applying to the process to be considered Centre of Excellence of the future European Reference Network? (1 = not interested at all, 5 = very interested) 2.15.1 Space for further comments:

. Proposed criteria for ERN (scope, general and specific criteria).1 Criteria related with diseases or conditions in order to be considered under the scope of the ERN.1.1. Need of highly specialised healthcare 5.1.1.1. Complexity of the diagnosis and treatment 5.1.1.2. High cost of treatment and resources.1.1.. Need of advanced/highly specialised medical equipment or infrastructures.1.2. Need of particular concentration of expertise and resources.1.2.1. Rare expertise/need of concentration of cases 5 5.1.2.2. Low prevalence/incidence/number of cases 5.1.2.. Evaluated experiences of Member States.1.. Based on high-quality, accessible and cost-effective healthcare.1..1. Evidence of the safety and favourable risk-benefit analysis

.1..2. Feasibility and evidence of the value and potential positive outcome (clinical).1.. Do you recommend any additional criteria or option that would effectively address the issue?.1..1 Explain your proposal in free text:.1.5. Would you prioritise or suggest any concrete disesase or group of diseases to be addressed by the future ERN according to the above criteria? Transparency to expertise and past performance.1.5.1 Explain your proposal in free text: Rare neurodegenerative diseases.2. General criteria of the centres wishing to join a European Reference Network.2.1. Organisation and management.2.2. Patients empowerment and centered care.2.. Patient care, clinical tools and health technology assessment.2.. Quality, patient safety and evaluation framework policies.2.5. Business continuity, contingency planning and response capacity.2.6. Information systems, technology and e-health tools and applications.2.7. Overall framework and capacity for research and training.2.8. Specific commitment of the management/direction of the centre/hospital to ensure a full and active participation in the ERN 2 2

.2.9. Do you recommend any additional option that would effectively address the issue?.2.9.1. Space for further comments: No..1. Competence, experience and good outcomes and care 5.. Specific criteria regarding the areas of expertise..2. Specific resources and organisation:..2.1. Human resources..2.2. Team/centre organisation 5..2.. Structural conditions..2.. Specific equipment..2.5. Presence and coordination with other required complementary units or services... Patient care pathways, protocols and clinical guidelines in the field of expertise... External coordination, care management and followup of patients..5. Research, training, health technology assessment in the field of expertise..6. Specific information systems 2..7. Do you recommend any additional criteria or option that would effectively address the issue? No

..7.1. Space for further comments: I think it would be important not to assign the ERN status through a topdown approach, but to let centres apply.